ARX788 in Breast Cancer With Low Expression of HER2

NCT05018676 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer With Low Expression of HER2

Interventions

DRUG: ARX788

Sponsor

Fudan University